Clinical Trial Update: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [Phase 3]

View source ↗

Summary

Final Phase 3 results for intravenous Mircera in treating anemia in dialysis patients were posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-09-14